LIMITED STAGE LUNG SMALL CELL CARCINOMA
Clinical trials for LIMITED STAGE LUNG SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE LUNG SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LIMITED STAGE LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients: experimental combo targets hard-to-treat tumors
Disease control OngoingThis early-phase trial tests a three-drug combination (tazemetostat, topotecan, and pembrolizumab) in adults with small cell lung cancer that has returned after initial treatment. The goal is to find the safest dose and see if the combination can shrink or stabilize tumors. About…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo aims to outsmart Chemo-Resistant lung cancer
Disease control OngoingThis study tests whether adding berzosertib to standard chemotherapy (topotecan) helps people with relapsed small cell lung cancer live longer without their cancer growing. About 104 participants will receive either the combo or topotecan alone. The goal is to see if blocking the…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Immunotherapy combo shows promise for tough lung cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemoradiation helps people with limited stage small cell lung cancer live longer. About 544 participants receive either chemoradiation alone or chemoradiation plus atezolizumab. The goal is to see if…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:14 UTC